Inventor

Heinz W. Pauls

Inventor
Oakville, CA

Overview

46→
Patents
1985–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 46 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes19%
C07BGeneral methods of organic chemistry6%
C07CAcyclic or carbocyclic compounds4%
C07KPeptides3%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
C30BSingle-crystal growth1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
C07HSugars1%
PatentTitleYear
11,104,681Solid forms of TTK inhibitor202111,059,832HPK1 inhibitors and methods of using same202110,919,886Salt and crystal forms of PLK-4 inhibitor202110,875,863RIPK2 inhibitors and method of treating cancer with same202010,584,130Solid forms of TTK inhibitor202010,570,143Pyrazolopyrimidine compounds202010,501,474HPK1 inhibitors and methods of using same2019RE047731Kinase inhibitors and method of treating cancer with same201910,472,353Salt and crystal forms of PLK-4 inhibitor201910,392,374Salt and crystal forms of PLK-4 inhibitor201910,358,436Kinase inhibitors and method of treating cancer201910,239,881RIPK2 inhibitors and method of treating cancer with same201910,167,289Pyrazolopyrimidine compounds201910,106,545Pyrazolopyrimidine compounds201810,077,255Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones20189,907,800'Kinase inhibitors and method of treating cancer'20189,884,855'Salt and crystal forms of PLK-4 inhibitor'20189,796,703'Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones'20179,657,025'Pyrazolopyrimidine compounds'20179,579,327'Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones'20179,580,390'Indazole compounds as kinase inhibitors and method of treating cancer with same'20179,573,954'Pyrazolopyrimidine compounds'20179,139,563'Kinase inhibitors and method of treating cancer'20158,999,968'Kinase inhibitors and method of treating cancer with same'20158,980,934'Kinase inhibitors and method of treating cancer with same'20158,921,545'Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones'20148,895,545'Acrylamide derivatives as Fab I inhibitors'20148,765,748'Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer'20148,680,282'Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer'20148,481,533'Kinase inhibitors and method of treating cancer'20138,481,525'Kinase inhibitors and method of treating cancer with same'20138,410,150'Inhibitors of carnitine palmitoyltransferase and treating cancer'20138,318,720'Acrylamide derivatives as Fab I inhibitors'20128,263,596'Kinase inhibitors and method of treating cancer'20127,947,684'1-aroyl-piperidinyl benzamidines'20117,790,709'Heterocyclic compounds, methods of making them and their use in therapy'20107,612,075'Substituted oxoazaheterocyclyl compounds'20097,361,663'N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa'20086,977,263'Chemical compounds'20056,323,227'Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides'20016,281,227'Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds'20016,034,093'Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds'20005,731,315'Substituted sulfonic acid n-›(aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds'19985,158,936'Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors'19925,055,451'Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors'19914,514,561'Process for preparing .alpha.-L N-acetyl daunosaminide'1985

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1991–1992Based in Mississauga, CA· patent location history
1998–2001Based in Collegeville, PA, US· patent location history
2008–2021Based in Oakville, CA· patent location history
2010Based in Toronto, CA· patent location history
2011Based in Flemington, NJ, US· patent location history
2012–2021Patents assigned to UNIV HEALTH NETWORK (32)· patent assignee history
2012–2015Patents assigned to PAULS HEINZ W (9)· patent assignee history
2012–2014Patents assigned to FORREST BRYAN T (7)· patent assignee history
2012–2014Patents assigned to LIU YONG (7)· patent assignee history
2012–2014Patents assigned to FEHER MIKLOS (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV HEALTH NETWORK322012–2021
PAULS HEINZ Wself92012–2015
FORREST BRYAN T72012–2014
LIU YONG72012–2014
FEHER MIKLOS62012–2014
Locations
LocationPatentsSpan
Oakville, CA362008–2021
Collegeville, Pennsylvania, US41998–2001
Mississauga, CA21991–1992
Flemington, New Jersey, US12011
Toronto, CA12010